Biolase Inc Reports Results For The Quarter Ended In March: Earnings Summary

November 26

13/05/2024 23:37

* BIOLASE Inc  BIOL.OQ  reported a quarterly adjusted loss
of 36
cents​​ per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of
$-18.00.  The mean expectation of three analysts for the quarter
was for a loss of 17 cents per share. Wall Street expected
results to range from -21 cents to -13 cents per share.
    * Revenue fell 3.2% to $10.13 million from a year ago;
analysts
expected $10.00 million. 
    * BIOLASE Inc's reported EPS for the quarter was a loss
of 36
cents​.
    * The company reported a quarterly loss of $6.49 million.
    * BIOLASE Inc shares had fallen by 11.0% this quarter and
lost 84.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 90.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

Wall Street's median 12-month price target for BIOLASE Inc is
$2.25 
This summary was machine generated from LSEG data May 13 at
10:37 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.17          -0.36          Missed
 Dec. 31 2023      -2.55          -1.76          Beat
 Sep. 30 2023      -1.85          -3.89          Missed
 Jun. 30 2023      -5.33          -8.24          Missed